Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• Non-coding RNAs (ncRNAs) constitute a significant portion of the mammalian genome, yet their roles in cancer remain largely unexplored.
• Understanding the functional implications of ncRNAs in oncogenesis is crucial for advancing cancer research and treatment.

Purpose of the Study:

• To identify novel non-coding RNA (ncRNA) genes implicated in breast cancer development.
• To characterize the regulatory and functional roles of these candidate ncRNAs in the context of breast cancer.

Main Methods:

• Analysis of de novo somatic point mutations in 1,855 breast cancer whole-genome sequences using the SomaGene tool.
• Integration of genomic data with regulatory features from ENCODE and FANTOM5, and genome-wide association study (GWAS) data.
• Utilizing Hi-C data to assess interactions between candidate ncRNAs and protein-coding gene promoters.

Main Results:

• Identification of 1030 candidate ncRNAs significantly mutated in breast cancer.
• Enrichment of candidate ncRNAs in active regulatory elements, including enhancers and accessible chromatin regions.
• Significant enrichment of breast cancer-associated GWAS single nucleotide polymorphisms (SNPs) within candidate ncRNAs.
• Demonstration that 82% of candidate ncRNAs interact with promoters of protein-coding genes, including known cancer-related genes.

Conclusions:

• The study identifies a novel set of non-coding RNA genes as potential drivers or key players in breast cancer.
• These ncRNAs are located in regulatory regions and interact with critical protein-coding genes, suggesting a role in regulating gene expression relevant to breast cancer.
• The findings provide a valuable resource for understanding the genetic basis of breast cancer and offer potential new targets for therapeutic intervention.